New pharmacotherapeutic approaches for the treatment of peripheral T-cell lymphoma
Today, it is difficult to overestimate the new directions in the pharmacotherapy of peripheral T-cell lymphomas (PTCL): immunotherapy, including adoptive, targeted therapy and chemotherapy. However, there are few biomarkers that predict response to therapy. A big problem is patients with refractory...
| প্রধান লেখক: | , , |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | Russian |
| প্রকাশিত: |
IRBIS LLC
2023-07-01
|
| মালা: | Фармакоэкономика |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://www.pharmacoeconomics.ru/jour/article/view/807 |